US biotech Arvinas today provided an update on its 2021 collaboration with pharma giant Pfizer for the co-development of ...

California, USA-based liver specialist 89bio saw its shares rocket more than 83% to $14.83 in pre-market activity on the news ...

China’s Mabwell (688062.SH) and Californian biotech venture firm Aditum Bio have combined to launch Kalexo Bio.

The European Commission (EC) has granted marketing authorization for US biotech major Biogen’s Zurzuvae (zuranolone) to treat ...

Regeneron Pharmaceuticals has announced the primary endpoint was met in the Phase III OPTIMA trial investigating garetosmab ...

The biologics supply chain has shifted from a technical backwater into a political and regulatory battleground. Vectors, ...

The European Court of Auditors has warned that Europe still lacks a reliable system to prevent and manage medicine shortages, ...

Deciphera, a subsidiary of Japan’s Ono Pharmaceutical, has received approval from the European Commission (EC) for Romvimza (vimseltinib) for the treatment of adult patients with symptomatic ...

Prota Therapeutics, an Australian biotech developing novel oral immunotherapy treatments that induce remission of allergy, ...

Spanish biotech ARTHEx has closed an expanded series B financing round totaling $87 million, led by French state-backed ...

South Korean biotech Alteogen (KOSDAQ:196170) has secured European Commission clearance for Eyluxvi (ALT-L9), its biosimilar ...

Belgian biopharma UCB has announced three-year data from the BE HEARD trials for Bimzelx (bimekizumab) in moderate to severe ...